Corerapeutic Services Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 16.10%
- Profit Growth 96.11%
- Ebitda 34.85%
- Net Worth 195.29%
- Total Assets 213.91%
About Corerapeutic Services
Corerapeutic Services Private Limited (CSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 24 February 2016 (Eight years and 11 months 7 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Corporate was formerly known as Corerapeutic Financial Services Private Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prem Kumar and Aakash Kumar serve as directors at the Company.
Company Details
-
Location
Ghaziabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74120UP2016PTC076836
-
Company No.
076836
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Feb 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Corerapeutic Services?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prem Kumar
|
Director | 24-Feb-2016 | Current |
|
Aakash Kumar
|
Director | 09-Dec-2020 | Current |
Financial Performance of Corerapeutic Services.
Corerapeutic Services Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.1% increase. The company also saw a substantial improvement in profitability, with a 96.11% increase in profit. The company's net worth Soared by an impressive increase of 195.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Corerapeutic Services?
Unlock access to Corerapeutic Services's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Corerapeutic Services?
Unlock and access historical data on people associated with Corerapeutic Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Corerapeutic Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corerapeutic Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
